Robert Spurr's Net Worth
$664 Thousand
Who is Robert Spurr?
Robert Spurr does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Bausch Health Companies Inc., and REPLIGEN CORP.
SEC CIK
Robert Spurr's CIK is 0001543795
Past Insider Trading and Trends
2022 was Robert Spurr's most active year for acquiring shares with 8 total transactions. Robert Spurr's most active month to acquire stocks was the month of February. 2022 was Robert Spurr's most active year for disposing of shares, totalling 12 transactions. Robert Spurr's most active month to dispose stocks was the month of January. 2022 saw Robert Spurr paying a total of $861,104.59 for 243,237 shares, this is the most they've acquired in one year. In 2022 Robert Spurr cashed out on 65,387 shares for a total of $1,250,908.69, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Bausch Health Companies Inc. (BHC) Snapshot price: $6.1229
President, U.S. Businesses
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +24.57% | 22.23K |
—
|
—
| 112.74K |
May 10
| |||
Form 4
| -1.73% | -1.59K |
$22.19 | -$35,393.05 | 90.51K |
Scheduled
|
Apr 14
| ||
Form 4
| -5.00% | -4.85K |
$22.20 | -$107,581.20 | 92.1K |
Scheduled
|
Mar 15
| ||
Form 4
| -4.03% | -4.07K |
$23.61 | -$96,187.14 | 96.95K |
Mar 3
| |||
Form 4
| +50.80% | 34.03K |
$23.77 | $823,829.44 | 101.02K |
Scheduled
|
Mar 2
| ||
Form 4
| +11.09% | 6.69K |
$24.35 | -$217,323.75 | 66.99K |
Feb 26 - Feb 27
| |||
Form 4
| -5.12% | -3.25K |
$25.02 | -$81,340.02 | 60.3K |
Scheduled
|
Feb 15
| ||
Form 4
| -4.87% | -3.25K |
$26.63 | -$86,574.13 | 63.55K |
Scheduled
|
Jan 18
| ||
Form 4
| -0.42% | -283.00 |
$28.60 | -$8,093.80 | 66.8K |
Oct 1
| |||
Form 4
| +15.55% | 9.03K |
—
|
—
| 67.08K |
Sep 1
| |||
Form 4
| -2.15% | -1.28K |
$28.95 | -$36,998.10 | 58.06K |
Aug 27
| |||
Form 4
| +67.41% | 23.89K |
—
|
—
| 59.34K |
Mar 3
| |||
Form 4
| -8.40% | -3.25K |
$31.42 | -$102,177.84 | 35.44K |
Mar 1
| |||
Form 4
| -0.71% | -276.00 |
$15.89 | -$4,385.64 | 38.7K |
Oct 2
| |||
Form 4
| -3.18% | -1.28K |
$17.00 | -$21,726.00 | 38.97K |
Aug 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
REPLIGEN CORP (RGEN) Snapshot price: $147.07
Chief Commercial. Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||